Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Wakame seaweed (Undaria pinnatifida) contains fucoidan, a sulfated polysaccharide that enhances NK cell activity by 30-50% and modulates NF-κB pathways to reduce inflammation. Fucoxanthin, its primary carotenoid, demonstrates antioxidant activity 13.5 times higher than vitamin E while supporting metabolic and cardiovascular health.
Reported Benefits (Provisional)
Origin & History
Wakame (Undaria pinnatifida) is an edible brown seaweed native to the coastal waters of Japan, Korea, and China. Known for its subtly sweet flavor and silky texture, it is a versatile ingredient in traditional East Asian cuisine. Wakame is celebrated for its rich profile of essential nutrients, minerals, and bioactive compounds, making it a valuable functional food.
Research Narrative (Provisional)
Scientific studies support Wakame's benefits for thyroid function, metabolic health, and cardiovascular wellness, primarily due to its iodine and fucoxanthin content. Research also highlights its role in immune resilience, bone density, and gut microbiome balance.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Minerals: Iodine, calcium, magnesium, potassium. - Vitamins: Vitamin A, C, D, K. - Fatty Acids: Omega-3 fatty acids. - Dietary Fiber: Alginates. - Phytochemicals/Bioactives: Fucoxanthin, sulfated polysaccharides, polyphenols.
Reported Mechanism (Provisional)
Fucoidan stimulates natural killer cell activity through immune pathway modulation and downregulates NF-κB inflammatory signaling cascades. Fucoxanthin acts as a potent antioxidant, neutralizing free radicals and supporting glucose metabolism through enhanced insulin sensitivity. The high iodine content supports thyroid hormone synthesis, while calcium and magnesium contribute to bone mineralization and cardiovascular function.
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and animal studies rather than human clinical trials. Laboratory research shows fucoidan increases NK cell activity by 30-50% in immune cell cultures and reduces inflammatory markers TNFα and IL-6 in LPS-stimulated macrophages. Fucoxanthin demonstrates antitumoral activity against A549, Malme-3M, and SiHa cancer cell lines in laboratory conditions. Human clinical data with specific dosages and outcomes remains limited, requiring more robust clinical investigation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.